Pneumonia Diagnostic Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: P5FE56CAEA86EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pneumonia Diagnostic in Global, including the following market information:

Global Pneumonia Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pneumonia Diagnostic market was valued at 470.5 million in 2021 and is projected to reach US$ 656.8 million by 2028, at a CAGR of 4.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Streptococcus-based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pneumonia Diagnostic include Abbott, Glaxo Smith Kline, Affymetrix, Becton Dickinson, BioMerieux, Cepheid and Diamedix/Erba, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumonia Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumonia Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pneumonia Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Streptococcus-based
• Legionella-based
• Chlamydophila-based
• Viral Pneumonia-based
• Mycoplasma Pneumonia-based

Global Pneumonia Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pneumonia Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Diagnostic Centres
• Others

Global Pneumonia Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pneumonia Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumonia Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pneumonia Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Glaxo Smith Kline
• Affymetrix
• Becton Dickinson
• BioMerieux
• Cepheid
• Diamedix/Erba

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pneumonia Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pneumonia Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PNEUMONIA DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Pneumonia Diagnostic Market Size: 2021 VS 2028
2.2 Global Pneumonia Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pneumonia Diagnostic Players in Global Market
3.2 Top Global Pneumonia Diagnostic Companies Ranked by Revenue
3.3 Global Pneumonia Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Pneumonia Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pneumonia Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pneumonia Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Pneumonia Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pneumonia Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pneumonia Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Streptococcus-based
  4.1.3 Legionella-based
  4.1.4 Chlamydophila-based
  4.1.5 Viral Pneumonia-based
  4.1.6 Mycoplasma Pneumonia-based
4.2 By Type - Global Pneumonia Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Pneumonia Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Pneumonia Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pneumonia Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Diagnostic Centres
  5.1.5 Others
5.2 By Application - Global Pneumonia Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Pneumonia Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Pneumonia Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pneumonia Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Pneumonia Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Pneumonia Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Pneumonia Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pneumonia Diagnostic Revenue, 2017-2028
  6.3.2 US Pneumonia Diagnostic Market Size, 2017-2028
  6.3.3 Canada Pneumonia Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Pneumonia Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pneumonia Diagnostic Revenue, 2017-2028
  6.4.2 Germany Pneumonia Diagnostic Market Size, 2017-2028
  6.4.3 France Pneumonia Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Pneumonia Diagnostic Market Size, 2017-2028
  6.4.5 Italy Pneumonia Diagnostic Market Size, 2017-2028
  6.4.6 Russia Pneumonia Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Pneumonia Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Pneumonia Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pneumonia Diagnostic Revenue, 2017-2028
  6.5.2 China Pneumonia Diagnostic Market Size, 2017-2028
  6.5.3 Japan Pneumonia Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Pneumonia Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Pneumonia Diagnostic Market Size, 2017-2028
  6.5.6 India Pneumonia Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pneumonia Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Pneumonia Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Pneumonia Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pneumonia Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Pneumonia Diagnostic Market Size, 2017-2028
  6.7.3 Israel Pneumonia Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Pneumonia Diagnostic Market Size, 2017-2028
  6.7.5 UAE Pneumonia Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Pneumonia Diagnostic Major Product Offerings
  7.1.4 Abbott Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Glaxo Smith Kline
  7.2.1 Glaxo Smith Kline Corporate Summary
  7.2.2 Glaxo Smith Kline Business Overview
  7.2.3 Glaxo Smith Kline Pneumonia Diagnostic Major Product Offerings
  7.2.4 Glaxo Smith Kline Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Glaxo Smith Kline Key News
7.3 Affymetrix
  7.3.1 Affymetrix Corporate Summary
  7.3.2 Affymetrix Business Overview
  7.3.3 Affymetrix Pneumonia Diagnostic Major Product Offerings
  7.3.4 Affymetrix Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Affymetrix Key News
7.4 Becton Dickinson
  7.4.1 Becton Dickinson Corporate Summary
  7.4.2 Becton Dickinson Business Overview
  7.4.3 Becton Dickinson Pneumonia Diagnostic Major Product Offerings
  7.4.4 Becton Dickinson Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Becton Dickinson Key News
7.5 BioMerieux
  7.5.1 BioMerieux Corporate Summary
  7.5.2 BioMerieux Business Overview
  7.5.3 BioMerieux Pneumonia Diagnostic Major Product Offerings
  7.5.4 BioMerieux Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 BioMerieux Key News
7.6 Cepheid
  7.6.1 Cepheid Corporate Summary
  7.6.2 Cepheid Business Overview
  7.6.3 Cepheid Pneumonia Diagnostic Major Product Offerings
  7.6.4 Cepheid Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Cepheid Key News
7.7 Diamedix/Erba
  7.7.1 Diamedix/Erba Corporate Summary
  7.7.2 Diamedix/Erba Business Overview
  7.7.3 Diamedix/Erba Pneumonia Diagnostic Major Product Offerings
  7.7.4 Diamedix/Erba Pneumonia Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Diamedix/Erba Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pneumonia Diagnostic Market Opportunities & Trends in Global Market
Table 2. Pneumonia Diagnostic Market Drivers in Global Market
Table 3. Pneumonia Diagnostic Market Restraints in Global Market
Table 4. Key Players of Pneumonia Diagnostic in Global Market
Table 5. Top Pneumonia Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pneumonia Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pneumonia Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pneumonia Diagnostic Product Type
Table 9. List of Global Tier 1 Pneumonia Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumonia Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pneumonia Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pneumonia Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pneumonia Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pneumonia Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pneumonia Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pneumonia Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pneumonia Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pneumonia Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pneumonia Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pneumonia Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pneumonia Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pneumonia Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pneumonia Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pneumonia Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Pneumonia Diagnostic Product Offerings
Table 32. Abbott Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Glaxo Smith Kline Corporate Summary
Table 34. Glaxo Smith Kline Pneumonia Diagnostic Product Offerings
Table 35. Glaxo Smith Kline Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Affymetrix Corporate Summary
Table 37. Affymetrix Pneumonia Diagnostic Product Offerings
Table 38. Affymetrix Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Becton Dickinson Corporate Summary
Table 40. Becton Dickinson Pneumonia Diagnostic Product Offerings
Table 41. Becton Dickinson Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. BioMerieux Corporate Summary
Table 43. BioMerieux Pneumonia Diagnostic Product Offerings
Table 44. BioMerieux Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Cepheid Corporate Summary
Table 46. Cepheid Pneumonia Diagnostic Product Offerings
Table 47. Cepheid Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Diamedix/Erba Corporate Summary
Table 49. Diamedix/Erba Pneumonia Diagnostic Product Offerings
Table 50. Diamedix/Erba Pneumonia Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pneumonia Diagnostic Segment by Type in 2021
Figure 2. Pneumonia Diagnostic Segment by Application in 2021
Figure 3. Global Pneumonia Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pneumonia Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumonia Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pneumonia Diagnostic Revenue in 2021
Figure 8. By Type - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pneumonia Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pneumonia Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Glaxo Smith Kline Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Affymetrix Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Becton Dickinson Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioMerieux Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cepheid Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Diamedix/Erba Pneumonia Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)